Dynamic Global Events (“DGE”), a life science leader in providing B2B conferences that engage audiences, facilitate information exchange, encourage collaboration, and accelerate partnerships, is proud to announce the Medical Affairs AI Immersion Lab event, scheduled for October 16-17. This unique event, focusing on hands-on working groups developing and editing AI work product in real-time, will empower participants to build a business case for AI among their teams and management.
The Medical Affairs AI Immersion Lab takes into account that AI is not “the coming thing” for pharma, but rather is already here and shaping the future; those who choose to actively adopt and leverage it stand to benefit the most out of what it has to offer. Guided by expert facilitators in a non-judgmental atmosphere, this event provides an opportunity to compare and contrast key platforms.
Over 20 industry experts are scheduled to speak at the event. Some of them include Anjali Mishra, a senior director, medical analytics and intelligence at Daiichi Sankyo; Todd Bresier, an associate director, IBD patient access and digital operations at Takeda; Vivek Mukhatyar, the generative AI medical engagement lead at Pfizer; and Chimene Richa, a medical education outcomes lead at AstraZeneca.
These speakers will discuss and offer their insights on various topics, such as the basics of prompt engineering, applications of large language models (“LLMs”) in medical affairs, deploying machine learning within CRMs to quantify team impact, and distinguishing simple, intermediate, and advanced applications.
The Medical Affairs AI Immersion Lab is an event unlike any other in the pharma industry. While many choose to dismiss or remain skeptical about AI in this space, this event looks to offer clarity and a chance for people to stay ahead of the curve and leverage fast-evolving AI tools to shape the work that they do. For those curious about AI in pharma, those looking to integrate it into their work, or even those already using AI in their workflow, this event is for you.
To learn more, please visit https://ibn.fm/yrXBp
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]
InvestorWire is powered by IBN